International Isotopes Inc. Announces Third Quarter and Nine Months 2007 Financi... (l Revenues Excluding Cobalt Products...)

International Isotopes Inc. Announces Third Quarter and Nine Months 2007 Financial Results

Date:11/12/2007

l Revenues Excluding

Cobalt Products Revenue $2,497,024 $2,769,635

The Radiological Services segment revenue decreased 32% and 10% respectively for the three and nine-month periods of 2007 compared to 2006 because of a short term reduction in contract services related to topaz processing. The Cobalt Products segment declined by about 8% and 28% respectively for the three and nine-month periods of 2007 compared to 2006 primarily due to the cyclic nature of bulk cobalt sales. The Radiochemical Products segment revenue increased by about 16% and 23% respectively for the three and nine-month periods of 2007 compared to 2006 as a result of continually improving sales in this segment. Also the Nuclear Medicine segment increased 23% and 5% respectively for the three and nine month period ended September 30, 2007 compared to the same period in 2006 as a result of strengthening sales.

GROSS PROFIT: Gross profit for the three-month periods ended September 30, 2007, and 2006, was $689,849 and $605,976 respectively, which represents an increase of $83,873 or 14%. Gross profit for the nine-month periods ended September 30, 2007, and 2006 was $1,618,879 and $1,673,696 respectively, which represents a decrease of $54,817 or 3%. Gross profit as a percentage of revenue increased, from 41.5% to 46.4%, for the three month periods ended September 30, 2006 and 2007, and decreased slightly, from 45.9% to 45.1%, for the nine-month periods ended September 30, 2006 and 2007 respectively.

NET LOSS: The Company's losses from operations for the three and nine- month periods ended September 30, 2007, were $276,287 and $1,146,281 respectively, as compared to losses from operations of $165,741 and $569,162 respectively for the comparable periods of 2006. The figures represent a 67% and 101% increase in loss for the three and nine-month periods respectively. The increase in loss is primarily due to an increase in general and administrative expenses ca
'/>"/>

0

GOOD

Page: 1 2 3 4
Related medicine news :

1. International study strengthens case for daily calcium pill
2. Mettler-Toledo International Inc. Announces Webcast of Presentation at Thomas Weisel Partners 2007 Healthcare Conference
3. Australian-led international study shows blood pressure drugs cut death rate in type 2 diabetes
4. LCA Hails International Investigators Studying Lung Cancer
5. Arrow International Urges Shareholders To Vote for Approval of the $45.50 Teleflex Inc. Merger and for the Current Board of Directors
6. PRA International Adds Dr. Susan Stansfield as Executive Vice President
7. Medical Services International Maintains Pace in Second Quarter
8. Clarity Imaging International, Inc. Rolls Out Mobile DEXA Program
9. International Gateway Insurance Brokers Partners With MEDILINQ
10. Tulane University to receive $14M for international HIV/AIDS program
11. International Database Seeks to Boost Treatment of Altitude Sickness

Post Your Comments:

International Isotopes Inc. Announces Third Quarter and Nine Months 2007 Financi...(l Revenues Excluding Cobalt Products...),Health